STAR Foundation extends vital research partnership with NIH until 2025

The STAR Foundation is thrilled to extend its collaboration with the National Institutes of Health (NIH) for another year, solidifying their commitment to pioneering research into 2025. This collaboration marks a significant milestone in the quest to advance medical knowledge and patient care.

The announcement was made with great enthusiasm by STAR, declaring the continuation of their groundbreaking work with the first-ever Natural History Study. This initiative aims to broaden the understanding of the disease by including a more extensive and diverse patient group. With this expansion, STAR and the NIH are set to engage with patients from various corners of the globe, including Brazil, Norway, The Dominican Republic, and The United States.

This renewed partnership signifies a crucial step forward in the fight against the disease, fostering international collaboration and knowledge exchange. The STAR Foundation, known for its unwavering dedication to improving patient outcomes in FSASD, including Salla Disease, is now poised to impact even more lives globally.  

As the organization celebrates this monumental achievement, their call to action resonates: "Let's continue to make a difference for this disease throughout our great world!" The extended partnership promises a future filled with hope and progress in the battle against this challenging medical condition.